Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts
- PMID: 29486013
- DOI: 10.1001/jama.2017.21897
Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts
Comment in
-
Off-label Use of Medications.JAMA. 2018 Jul 17;320(3):306-307. doi: 10.1001/jama.2018.6517. JAMA. 2018. PMID: 30027244 No abstract available.
Comment on
-
Gabapentin for Chronic Neuropathic Pain.JAMA. 2018 Feb 27;319(8):818-819. doi: 10.1001/jama.2017.21547. JAMA. 2018. PMID: 29486015
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources